Patents
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
12/2010
12/09/2010CA2760655A1 Heterocyclic compounds and expansion agents for hematopoietic stem cells
12/08/2010EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides
12/08/2010EP2258687A1 Nicotinamide derivates useful as P38 inhibitors
12/08/2010EP2258379A1 Use of platelet rich plasma composition
12/08/2010EP2257340A2 Compounds for treating muscular dystrophy
12/08/2010EP1884237B1 Amidino derivatives for use in the prevention or treatment of glaucoma
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010CN201664142U Moxa good-smelling pillow for cerebral-heart comfort
12/08/2010CN1977837B Application of monoesters of probucol for the treatment of cardiovascular and inflammatory disease
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN1530102B Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases
12/08/2010CN101909651A External preparation composition comprising fatty acid-based ionic liquid as active ingredient
12/08/2010CN101906106A Novel heterocyclic compounds as HSP90-inhibitors
12/08/2010CN101904969A Traditional Chinese medicine composition for treating proliferative diseases and preparation method thereof
12/08/2010CN101342364B Medicament for treating lumbar muscle degeneration and preparation method thereof
12/07/2010US7847068 Neutralizing human anti-IGFR antibody
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010CA2514816C Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2368850C Methods for the prevention and/or the treatment of glutamate cytotoxicity
12/02/2010WO2010138670A2 Thiocolchicine derivatives, method of making and methods of use thereof
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010136508A2 Stem cell targeting
12/02/2010US20100305194 Modified and stabilized gdf propeptides and uses thereof
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305165 Thiocolchicine derivatives, method of making and methods of use thereof
12/02/2010US20100305147 Chemically modified small molecules
12/02/2010US20100305120 Compounds for treating muscular dystrophy
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305101 Leptin genotype and ß-adrenergic agonists
12/02/2010US20100305036 Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders
12/02/2010CA2763446A1 Stem cell targeting
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010CN101897970A Compositions and methods for treating diabetes
12/01/2010CN101897964A Medicament for preventing autoimmune disease
12/01/2010CN101897810A Traditional Chinese medicine for treating traumatic injury of tendon and muscle
12/01/2010CN101897766A Anti-inflammatory and analgesic medicine composition as well as preparation method and application thereof
12/01/2010CN101897724A Method for producing a soft tissue filler and method for producing an adipose tissue transplant
12/01/2010CN101337030B Medicine composition for reducing swelling and easing pain, preparation method and use thereof
11/2010
11/30/2010CA2326653C Compositions and methods of adjusting steroid hormone metabolism through facilitated absorption of hydrophobic dietary compounds
11/25/2010WO2010132982A1 Treatment of muscle disease characterized by insulin resistance
11/25/2010WO2010064248A3 Methods of diagnosing and treating motor neuron diseases
11/25/2010CA2762351A1 Treatment of muscle disease characterized by insulin resistance
11/24/2010EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody
11/24/2010EP2091531B1 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt
11/24/2010EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/24/2010CN201640466U Health-care underpants
11/24/2010CN1942181B Tablet containing branched chain amino acid and process for producing the same
11/24/2010CN101896186A Means and methods for counteracting muscle disorders
11/24/2010CN101891812A Mechano growth factor polypeptide, preparation method and application thereof
11/24/2010CN101891680A Modulators of atp-binding cassette transporters
11/23/2010US7838518 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease
11/23/2010US7838289 Assay utilizing multipotent adult stem cells
11/23/2010CA2480776C Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
11/23/2010CA2461068C Cell populations which co-express cd49c and cd90
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/18/2010WO2010131712A1 Therapeutic pharmaceutical agent for diseases associated with decrease in function of gne protein, food composition, and food additive
11/18/2010WO2010131382A1 Muscle repair promoter
11/18/2010WO2010130799A2 Method for impregnation with supercritical co2
11/18/2010US20100292306 Compositions And Methods For The Treatment Of Muscular Dystrophy
11/18/2010US20100292297 Micrornas That Regulate Muscle Cell Proliferation and Differentiation
11/18/2010US20100292270 Treatment of cachexia
11/18/2010US20100292254 Fused Pyrimidine Derivatives as Trpv3 Modulators
11/18/2010US20100292205 Pyrimidone Compounds As GSK-3 Inhibitors
11/18/2010US20100292142 Novel neurotrophic factors
11/18/2010US20100291160 Pharmaceutical system for trans-membrane delivery
11/18/2010US20100291028 Use of il-18 inhibitors for treatment and/or prevention of peripheral vascular diseases
11/18/2010US20100290995 Radio-opaque compounds, compositions containing same and methods of their synthesis and use
11/17/2010EP2249874A1 Methods and means for treating dna repeat instability associated genetic disorders
11/17/2010EP2249860A2 Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy
11/17/2010EP2249842A1 Use of 25-hydroxy-vitamin d3 to affect human muscle physiology
11/17/2010CN101884765A Medicament for treating big belly known as beer belly
11/16/2010US7834020 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia
11/16/2010US7833993 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia
11/16/2010CA2479084C Vdac regulator
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2415643C Pharmaceutical composition for oral use with improved absorption
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/16/2010CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition
11/11/2010WO2010129406A2 Methods of promoting muscle growth
11/11/2010WO2010129273A2 Butaclamol for the treatment of amyotrophic lateral sclerosis
11/11/2010WO2010128243A1 Method for preparing polyphenol extracts from spinach leaves
11/11/2010US20100286275 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
11/11/2010US20100286146 Carboxamide compounds and their use as calpain inhibitors
11/11/2010US20100286023 Compositions and Methods for Increasing Muscle Mass, Strength, and Functional Performance in the Elderly
11/11/2010US20100285073 a micro-rna family that modulates fibrosis and uses thereof
11/11/2010US20100285031 Hox Compositions and Methods
11/11/2010CA2761143A1 Method for preparing polyphenol extracts from spinach leaves
11/11/2010CA2759801A1 Gene therapy for neurodegenerative disorders
11/10/2010EP2247288A1 Use of hedgehog agonists in the treatment of musculoskeletal-related disorders
11/10/2010EP0958362B1 Isolation and use of motoneuronotrophic factors
11/10/2010CN101883579A Combination of protein tyrosine phosphatase inhibitors and human growth hormone for the treatment of muscle atrophy and related disorders
11/10/2010CN101880283A Azaindole kinase inhibitors
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 233